Back
Cue Biopharma Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Cue Biopharma Stock Forecast
-
Is Cue Biopharma Stock Undervalued?
The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Cue Biopharma Stock Go Up Next Year?
Data Unavailable
Cue Biopharma Stock Rating
Data Unavailable
Cue Biopharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cuebiopharma.com
52-Week Data
52-Week High:
3.25
52-Week Low:
0.45
Prediction Charts
Market Cap:
90.31M
Price in USD:
1.50
Volume:
1.32M
Beta:
1.69
Technical Analysis
SMA50:
1.12
SMA100:
0.97
SMA200:
1.41
52-Wk Change:
-39.02%
Stock Predictions
-
Is Cue Biopharma stock public?
Yes, Cue Biopharma is a publicly traded company. -
What is the Cue Biopharma stock quote today?
The Cue Biopharma stock price is 1.50 USD today. -
How to buy Cue Biopharma stock online?
You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-28 | 1.46 | 1.78 | 1.86 | 1.46 |
| Oct-29 | 1.75 | 1.69 | 1.95 | 1.60 |
| Oct-30 | 1.71 | 1.75 | 1.90 | 1.69 |
| Oct-31 | 1.72 | 1.60 | 1.74 | 1.48 |
| Nov-1 | 1.65 | 1.52 | 1.69 | 1.43 |
| Nov-4 | 1.51 | 1.49 | 1.64 | 1.45 |
| Nov-5 | 1.48 | 1.71 | 1.74 | 1.32 |
| Nov-6 | 1.76 | 1.65 | 1.89 | 1.56 |
| Nov-7 | 1.65 | 1.78 | 1.90 | 1.59 |
| Nov-8 | 1.79 | 1.72 | 1.87 | 1.64 |
| Nov-11 | 1.70 | 1.86 | 1.99 | 1.69 |
| Nov-12 | 1.88 | 1.69 | 1.92 | 1.61 |
| Nov-13 | 1.71 | 1.50 | 1.84 | 1.46 |
| Nov-14 | 1.58 | 1.50 | 1.60 | 1.45 |
Cue Biopharma Earnings
Data Unavailable
Cue Biopharma Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.